Here, we compared the three viruses RL1-LAT-HSV-2, LAT-HSV-2 and HSV-2 administered at a dose of 5 × 104 PFUs via the nasal mucosa and genital tract, and clinical observations were made within 15 days of virus infection (Figure 2). The gene discussed is LAT; the disease is viral infectious disease.